Jump to content

Unlocking Opportunities in ATMP Development: NGS for Starting Material, Product Characterization and Release Testing in a GMP Environment

February 9, 2024

Genedata Selector® is an enterprise software platform that uses next-generation sequencing (NGS) data to select, optimize, and characterize producer cell lines and viral vectors expressing cloned genes for ATMPs (Advanced Therapy Medicinal Products). It automates the critical quality attributes (CQAs) testing of ATMPs, ensuring their identity, purity, potency, and safety. This helps biopharmaceutical companies produce high-quality ATMPs that meet good manufacturing practice (GMP) requirements and clinical standards, reducing development costs and time-to-market.


Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy